Healthpeak Properties Inc. (NYSE:PEAK) went up by 0.25% from its latest closing price compared to the recent 1-year high of $37.69. The company’s stock price has collected -2.02% of loss in the last five trading sessions. Press Release reported on 01/10/22 that Healthpeak Properties to Report Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call/Webcast
Is It Worth Investing in Healthpeak Properties Inc. (NYSE :PEAK) Right Now?
Healthpeak Properties Inc. (NYSE:PEAK) scored a price-to-earnings ratio above its average ratio, recording 289.68 x from its present earnings ratio. Plus, the 36-month beta value for PEAK is at 0.72. Opinions of the stock are interesting as 9 analysts out of 19 who provided ratings for Healthpeak Properties Inc. declared the stock was a “buy,” while 3 rated the stock as “overweight,” 7 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $37.97, which is $1.93 above the current price. PEAK currently public float of 537.95M and currently shorts hold a 1.21% ratio of that float. Today, the average trading volume of PEAK was 2.81M shares.
PEAK’s Market Performance
PEAK stocks went down by -2.02% for the week, with a monthly jump of 6.30% and a quarterly performance of 6.46%, while its annual performance rate touched 25.55%. The volatility ratio for the week stands at 1.66% while the volatility levels for the past 30 days are set at 1.81% for Healthpeak Properties Inc.. The simple moving average for the period of the last 20 days is 1.25% for PEAK stocks with a simple moving average of 4.13% for the last 200 days.
Analysts’ Opinion of PEAK
Many brokerage firms have already submitted their reports for PEAK stocks, with JP Morgan repeating the rating for PEAK by listing it as a “Overweight.” The predicted price for PEAK in the upcoming period, according to JP Morgan is $40 based on the research report published on December 20th of the previous year 2021.
Mizuho gave a rating of “Neutral” to PEAK, setting the target price at $32 in the report published on July 14th of the previous year.
PEAK Trading at 3.48% from the 50-Day Moving Average
After a stumble in the market that brought PEAK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.70% of loss for the given period.
Volatility was left at 1.81%, however, over the last 30 days, the volatility rate increased by 1.66%, as shares surge +4.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.15% upper at present.
During the last 5 trading sessions, PEAK fell by -2.02%, which changed the moving average for the period of 200-days by +13.24% in comparison to the 20-day moving average, which settled at $35.55. In addition, Healthpeak Properties Inc. saw -0.47% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at PEAK starting from GARVEY CHRISTINE, who sale 300 shares at the price of $34.35 back on Nov 19. After this action, GARVEY CHRISTINE now owns 22,709 shares of Healthpeak Properties Inc., valued at $10,306 using the latest closing price.
GARVEY CHRISTINE, the Director of Healthpeak Properties Inc., sale 575 shares at $36.20 during a trade that took place back on Sep 09, which means that GARVEY CHRISTINE is holding 23,009 shares at $20,813 based on the most recent closing price.
Stock Fundamentals for PEAK
Current profitability levels for the company are sitting at:
- -2.80 for the present operating margin
- +5.47 for the gross margin
The net margin for Healthpeak Properties Inc. stands at +8.74. The total capital return value is set at -0.34, while invested capital returns managed to touch 1.11.
Based on Healthpeak Properties Inc. (PEAK), the company’s capital structure generated 97.55 points at debt to equity in total, while total debt to capital is 49.38. Total debt to assets is 41.60, with long-term debt to equity ratio resting at 95.45. Finally, the long-term debt to capital ratio is 48.32.
When we switch over and look at the enterprise to sales, we see a ratio of 14.00, with the company’s debt to enterprise value settled at 0.29. The receivables turnover for the company is 6.75 and the total asset turnover is 0.11.